The Sobrato Cancer Center at Santa Clara Valley Medical Center (SCVMC) has been recognized by the Quality Oncology Practice Initiative Certification Program. The SCVMC is the only public/government hospital in California to receive certification, which demonstrates a commitment to excellence and ongoing quality improvement.
“High standards for treatment must be achieved to receive certification,” stated Dr. Lee Levitt, Chief of the Oncology Department at SCVMC. “We are very proud of this accomplishment. Everyone on this team works toward the same goal, making sure our patients get high-quality, safe and outstanding care.”
The Quality Oncology Practice Initiative (QOPI®) Certification Program is an affiliate of the American Society of Clinical Oncology. The certification is for three years from designation, which was achieved on March 26, 2013.
This certification program is the first of its kind for oncology in the United States. The Sobrato Cancer Center achieved certification by meeting core standards in all areas of treatment, including:
- Treatment planning;
- Staff training and education;
- Chemotherapy orders and drug preparation;
- Patient consent and education;
- Safe chemotherapy administration;
- Monitoring and assessment of patient well-being.
“Oncology practices that are committed to quality and safety are those that provide the most optimal cancer care,” said ASCO President Sandra M. Swain, MD, FACP. “ASCO’s quality programs are designed by leaders in the profession and give practices the ability to continuously improve the quality of care they provide. The QOPI Certification Program helps practices determine whether they are providing the best treatment and care possible to their patients, and demonstrates a commitment to excellence and ongoing quality improvement in the hematology-oncology outpatient practice.”
The Sobrato Cancer Center is named for the family of Silicon Valley philanthropist John A. Sobrato. In 2006, the Sobrato family donated $1,000,000 to the Valley Medical Center Foundation to help fund the purchase of a new linear accelerator for the Center.